PL1651260T5 - Lawsonia intracellularis pochodzenia europejskiego oraz szczepionki, środki diagnostyczne i sposoby ją wykorzystujące - Google Patents

Lawsonia intracellularis pochodzenia europejskiego oraz szczepionki, środki diagnostyczne i sposoby ją wykorzystujące

Info

Publication number: PL1651260T5
Authority: PL; Poland
Prior art keywords: intracellularis; vaccines; methods; diagnostic agents; lawsonia intracellularis
Prior art date: 2003-07-25

Application number

PL04778282T

Other languages

English (en)

Other versions

PL1651260T3 (pl

Inventor

Michael B Roof

Jeremy J. Kroll

Jeffrey P. Knittel

Original Assignee

Boehringer Ingelheim Vetmedica, Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-07-25

Filing date

2004-07-15

Publication date

2018-11-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34115340&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1651260(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-07-15 Application filed by Boehringer Ingelheim Vetmedica, Inc. filed Critical Boehringer Ingelheim Vetmedica, Inc.

2010-02-26 Publication of PL1651260T3 publication Critical patent/PL1651260T3/pl

2018-11-30 Publication of PL1651260T5 publication Critical patent/PL1651260T5/pl

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Gram-negative bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/825—Bacterial vaccine for porcine species, e.g. swine

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Immunology (AREA)
Pharmacology & Pharmacy (AREA)
Genetics & Genomics (AREA)
Animal Behavior & Ethology (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Microbiology (AREA)
Mycology (AREA)
Chemical Kinetics & Catalysis (AREA)
Zoology (AREA)
Biophysics (AREA)
Wood Science & Technology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Biotechnology (AREA)
Tropical Medicine & Parasitology (AREA)
Virology (AREA)
Biomedical Technology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
General Engineering & Computer Science (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PL04778282T 2003-07-25 2004-07-15 Lawsonia intracellularis pochodzenia europejskiego oraz szczepionki, środki diagnostyczne i sposoby ją wykorzystujące PL1651260T5 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US49000103P	2003-07-25	2003-07-25
PCT/US2004/022704 WO2005011731A1 (en)	2003-07-25	2004-07-15	Lawsonia intracellularis of european origin and vaccines, diagnostic agents and methods of use thereof
EP04778282.6A EP1651260B2 (en)	2003-07-25	2004-07-15	Lawsonia intracellularis of european origin and vaccines, diagnostic agents and methods of use thereof

Publications (2)

Publication Number	Publication Date
PL1651260T3 PL1651260T3 (pl)	2010-02-26
PL1651260T5 true PL1651260T5 (pl)	2018-11-30

Family

ID=34115340

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL04778282T PL1651260T5 (pl)	2003-07-25	2004-07-15	Lawsonia intracellularis pochodzenia europejskiego oraz szczepionki, środki diagnostyczne i sposoby ją wykorzystujące

Country Status (23)

Country	Link
US (2)	US7312065B2 (pl)
EP (1)	EP1651260B2 (pl)
JP (1)	JP2006528882A (pl)
KR (1)	KR101131845B1 (pl)
CN (2)	CN1829529B (pl)
AT (1)	ATE442163T2 (pl)
AU (1)	AU2004260657B2 (pl)
BR (1)	BRPI0412911B1 (pl)
CA (1)	CA2533559C (pl)
CY (1)	CY1109652T1 (pl)
DE (1)	DE602004023094D1 (pl)
DK (1)	DK1651260T4 (pl)
ES (1)	ES2333334T5 (pl)
MX (1)	MXPA06000994A (pl)
MY (1)	MY140208A (pl)
PL (1)	PL1651260T5 (pl)
PT (1)	PT1651260E (pl)
RU (1)	RU2420570C2 (pl)
SG (1)	SG144909A1 (pl)
SI (1)	SI1651260T2 (pl)
UA (1)	UA87665C2 (pl)
WO (1)	WO2005011731A1 (pl)
ZA (1)	ZA200510081B (pl)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2772047B1 (fr) *	1997-12-05	2004-04-09	Ct Nat D Etudes Veterinaires E	Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
US7833707B2 (en)	2004-12-30	2010-11-16	Boehringer Ingelheim Vetmedica, Inc.	Methods of overexpression and recovery of porcine circovirus type 2 ORF2
UA95602C2 (ru)	2004-12-30	2011-08-25	Берингер Ингельхейм Ветмедика, Инк.	Иммуногенная композиция цвс2 и способы приготовления такой композиции
US8834891B2 (en) *	2005-03-14	2014-09-16	Boehringer Ingelheim Vetmedica, Inc.	Immunogenic compositions comprising Lawsonia intracellularis
AU2012207016B2 (en) *	2005-03-14	2015-01-15	Boehringer Ingelheim Animal Health USA Inc.	Immunogenic compositions comprising Lawsonia intracellularis
US8398994B2 (en) *	2005-07-15	2013-03-19	Boehringer Ingelheim Vetmedica, Inc.	Lawsonia vaccine and methods of use thereof
MX338626B (es)	2005-12-29	2016-04-26	Boehringer Ingelheim Vetmed	Uso de una composicion inmunogenica de pcv2 para producir los sintomas clinicos en cerdos.
EP2275132B1 (en)	2005-12-29	2021-03-03	Boehringer Ingelheim Animal Health USA Inc.	Multivalent PCV2 immunogenic compositions and methods of producing them
US8470336B2 (en) *	2006-05-25	2013-06-25	Boehringer Ingelheim Vetmedica, Inc.	Vaccination of young animals against Lawsonia intracellularis infections
US20080241190A1 (en) *	2006-11-13	2008-10-02	Boehringer Ingelheim Vetmedica, Inc.	Vaccination of horses against lawsonia intracellularis
EP2099927A4 (en) *	2006-11-22	2010-05-05	Boehringer Ingelheim Vetmed	Methods of reducing porcine circovirus-associated disease outbreaks
EP2859900A1 (en)	2006-12-11	2015-04-15	Boehringer Ingelheim Vetmedica, Inc.	Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
BRPI0721083A2 (pt) *	2006-12-15	2014-02-25	Boehringer Ingelheim Vetmed	Tratamento de porcos com antígeno de pcv2
EP1941903A1 (en)	2007-01-03	2008-07-09	Boehringer Ingelheim Vetmedica Gmbh	Prophylaxis and treatment of PRDC
EP1958644A1 (en) *	2007-02-13	2008-08-20	Boehringer Ingelheim Vetmedica Gmbh	Prevention and treatment of sub-clinical pcvd
US7829274B2 (en)	2007-09-04	2010-11-09	Boehringer Ingelheim Vetmedica, Inc.	Reduction of concomitant infections in pigs by the use of PCV2 antigen
TW200918666A (en) *	2007-09-11	2009-05-01	Wyeth Corp	Attenuated mycoplasma gallisepticum strains
EP2200643B1 (en)	2007-09-17	2013-09-04	Boehringer Ingelheim Vetmedica, Inc.	A live lawsonia intracellularis vaccine administered in combination with an antibiotic for use in the treatment of lawsonia intracellularis infections in pigs
JP2011508595A (ja) *	2007-12-31	2011-03-17	ベーリンガーインゲルハイムフェトメディカインコーポレイテッド	外来性アミノ酸の挿入を含むｐｃｖ２ｏｒｆ２ウイルス様粒子
JP5613061B2 (ja) *	2008-01-23	2014-10-22	ベーリンガーインゲルハイムフェトメディカインコーポレイテッド	Ｐｃｖ２マイコプラズマ・ハイオニューモニエ免疫原性組成物および前記組成物の製造方法
US20110033495A1 (en) *	2008-02-15	2011-02-10	Boehringer Ingelheim Vetmedica, Inc.	Methods and compositions for reducing the impact of enteric diseases
TWI551295B (zh)	2008-04-18	2016-10-01	英特威特國際股份有限公司	防備胞內勞森菌（Ｌａｗｓｏｎｉａｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
TWI449533B (zh)	2008-04-18	2014-08-21	Intervet Int Bv	防備胞內勞森菌（Ｌａｗｓｏｎｉａｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅｃｉｒｃｏｖｉｒｕｓ）用疫苗
ES2534556T3 (es) *	2008-07-22	2015-04-24	Intervet International Bv	Bacteria Lawsonia intracellularis de un nuevo serotipo, vacuna basada en esa bacteria, anticuerpos adecuados para diagnosticar el nuevo serotipo de Lawsonia intracellularis e hibridomas para producir dichos anticuerpos
US8142760B2 (en) *	2008-09-05	2012-03-27	Nathan Len Winkelman	Vaccination for Lawsonia intracellularis
WO2011006880A1 (en) *	2009-07-14	2011-01-20	Intervet International B.V.	Lawsonia intracellularis propagation
TWI627281B (zh)	2009-09-02	2018-06-21	百靈佳殷格翰家畜藥品公司	降低ｐｃｖ－２組合物殺病毒活性之方法及具有改良免疫原性之ｐｃｖ－２組合物
EP2499233B1 (en)	2009-11-09	2016-11-02	Intervet International B.V.	Method to grow lawsonia intracellularis bacteria in persistently infected mccoy cells
WO2011119920A2 (en)	2010-03-25	2011-09-29	Oregon Health & Science University	Cmv glycoproteins and recombinant vectors
SMT201800284T1 (it)	2011-06-10	2018-07-17	Univ Oregon Health & Science	Glicoproteine cmv e vettori ricombinanti
KR102319843B1 (ko)	2013-09-25	2021-10-29	조에티스 서비시즈 엘엘씨	Pcv2b 분지형 백신 조성물 및 사용 방법
US9505808B2 (en)	2013-10-02	2016-11-29	Boehringer Ingelheim Vetmedica, Inc.	PCV2 ORF2 protein variant and virus like particles composed thereof
EP3076995B1 (en)	2013-12-03	2020-03-11	Intervet International B.V.	Vaccine against lawsonia intracellularis and porcine circovirus 2
CN103823063B (zh) *	2014-02-25	2015-09-30	上海理工大学	检测猪霍乱沙门氏菌的方法及其单抗
EP3253410B1 (en)	2015-02-04	2020-05-06	Intervet International B.V.	A vaccine for use against subclinical lawsonia infection in a pig
KR101893827B1 (ko) *	2016-01-04	2018-08-31	전북대학교 산학협력단	약독화된 살모넬라 변이주를 유효성분으로 포함하는 돼지 증식성 회장염 및 살모넬라증 동시 예방 또는 치료용 백신 조성물
JP7139437B2 (ja) *	2018-02-28	2022-09-20	ベーリンガーインゲルハイムフェトメディカゲーエムベーハー	動物内のスカトール及び／又はインドールの低減方法
KR102249189B1 (ko) *	2020-01-09	2021-05-07	전북대학교 산학협력단	항원성이 증진된 항원을 발현하는 약독화된 살모넬라 변이주를 유효성분으로 포함하는 돼지 증식성 회장염 및 살모넬라증 동시 예방 또는 치료용 백신 조성물
CA3185751A1 (en) *	2020-07-24	2022-01-27	Edgar DIAZ	Combination porcine vaccine
CN111961627A (zh) *	2020-08-27	2020-11-20	南京农业大学	一种胞内劳森菌的分离与培养方法
WO2023073640A1 (en)	2021-11-01	2023-05-04	Boehringer Ingelheim Vetmedica Gmbh	Immunogenic gel compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5714375A (en)	1995-06-05	1998-02-03	Nobl Laboratories, Inc.	Ileal symbiont intracellularis propagation in suspended host cells
US5885823A (en) *	1995-06-05	1999-03-23	Nobl Laboratories, Inc.	Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents

2004
- 2004-07-15 UA UAA200601775A patent/UA87665C2/ru unknown
- 2004-07-15 PT PT04778282T patent/PT1651260E/pt unknown
- 2004-07-15 BR BRPI0412911A patent/BRPI0412911B1/pt active IP Right Grant
- 2004-07-15 RU RU2006105715/10A patent/RU2420570C2/ru active
- 2004-07-15 CN CN200480021627XA patent/CN1829529B/zh not_active Expired - Lifetime
- 2004-07-15 DE DE602004023094T patent/DE602004023094D1/de not_active Expired - Lifetime
- 2004-07-15 ES ES04778282.6T patent/ES2333334T5/es not_active Expired - Lifetime
- 2004-07-15 DK DK04778282.6T patent/DK1651260T4/en active
- 2004-07-15 SG SG200805019-7A patent/SG144909A1/en unknown
- 2004-07-15 WO PCT/US2004/022704 patent/WO2005011731A1/en not_active Ceased
- 2004-07-15 SI SI200431296T patent/SI1651260T2/sl unknown
- 2004-07-15 MX MXPA06000994A patent/MXPA06000994A/es active IP Right Grant
- 2004-07-15 AT AT04778282T patent/ATE442163T2/de active
- 2004-07-15 US US10/891,745 patent/US7312065B2/en not_active Expired - Lifetime
- 2004-07-15 KR KR1020067001755A patent/KR101131845B1/ko not_active Expired - Lifetime
- 2004-07-15 JP JP2006521125A patent/JP2006528882A/ja active Pending
- 2004-07-15 CN CNA2008101760745A patent/CN101423811A/zh active Pending
- 2004-07-15 PL PL04778282T patent/PL1651260T5/pl unknown
- 2004-07-15 CA CA2533559A patent/CA2533559C/en not_active Expired - Lifetime
- 2004-07-15 AU AU2004260657A patent/AU2004260657B2/en not_active Expired
- 2004-07-15 EP EP04778282.6A patent/EP1651260B2/en not_active Expired - Lifetime
- 2004-07-23 MY MYPI20042965A patent/MY140208A/en unknown
2005
- 2005-12-12 ZA ZA200510081A patent/ZA200510081B/en unknown
2007
- 2007-11-06 US US11/935,447 patent/US7758870B2/en not_active Expired - Lifetime
2009
- 2009-11-25 CY CY20091101223T patent/CY1109652T1/el unknown

Also Published As

Publication number	Publication date
US7312065B2 (en)	2007-12-25
US20080112980A1 (en)	2008-05-15
PT1651260E (pt)	2009-09-24
SI1651260T1 (sl)	2010-01-29
JP2006528882A (ja)	2006-12-28
ZA200510081B (en)	2006-08-30
BRPI0412911A (pt)	2006-09-26
EP1651260B2 (en)	2018-06-27
MXPA06000994A (es)	2006-05-15
RU2006105715A (ru)	2007-09-10
ES2333334T5 (es)	2018-08-06
EP1651260A1 (en)	2006-05-03
EP1651260B1 (en)	2009-09-09
CA2533559C (en)	2013-07-02
ES2333334T3 (es)	2010-02-19
US7758870B2 (en)	2010-07-20
DK1651260T4 (en)	2018-10-08
KR20060054352A (ko)	2006-05-22
US20050031647A1 (en)	2005-02-10
KR101131845B1 (ko)	2012-03-30
AU2004260657A1 (en)	2005-02-10
CN101423811A (zh)	2009-05-06
SI1651260T2 (sl)	2018-09-28
CN1829529A (zh)	2006-09-06
AU2004260657B2 (en)	2012-06-07
DK1651260T3 (da)	2010-01-11
RU2420570C2 (ru)	2011-06-10
CA2533559A1 (en)	2005-02-10
BRPI0412911B1 (pt)	2020-01-21
WO2005011731A1 (en)	2005-02-10
DE602004023094D1 (de)	2009-10-22
SG144909A1 (en)	2008-08-28
UA87665C2 (ru)	2009-08-10
CN1829529B (zh)	2011-05-04
MY140208A (en)	2009-11-30
PL1651260T3 (pl)	2010-02-26
CY1109652T1 (el)	2014-08-13
ATE442163T2 (de)	2009-09-15

Publication	Publication Date	Title
PL1651260T3 (pl)	2010-02-26	Lawsonia intracellularis pochodzenia europejskiego oraz szczepionki, środki diagnostyczne i sposoby ją wykorzystujące
MXPA01011047A (es)	2003-10-14	Secuencias genomicas de neisseria y metodos para su uso.
MXPA01003557A (es)	2004-04-05	Secuencias genomicas de neisseria y metodos para su uso.
SI2351579T1 (sl)	2017-05-31	Polipeptidna cepiva za široko zaščito proti hipervirulentnim meningokoknim linijam
WO2008112344A3 (en)	2009-12-30	Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins
WO2007064742A3 (en)	2007-08-09	Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus (prrsv) and uses thereof
CY1107950T1 (el)	2013-09-04	Νεϊσσεριακες συνθεσεις εμβολιου και μεθοδοι
CY1109210T1 (el)	2014-07-02	Διαγραφεισες αλληλουχιες στο μ. bovis bcg/m. bovis ΄η μ. tuberculosis, μεθοδος ανιχνευσεως μυκοβακτηριων που χρησιμοποιουν αυτες τις αλληλουχιες και εμβολια
MX2012003827A (es)	2012-08-03	Toxina rtx citolitica de gallibacterium anatis.
da Silva et al.	2014	Identification of linear B epitopes of pertactin of Bordetella pertussis induced by immunization with whole and acellular vaccine
PL1796717T3 (pl)	2012-08-31	Szczepionka skojarzona
TW200510524A (en)	2005-03-16	Lawsonia intracellularis of european origin and vaccines, diagnostic agents and methods of use thereof
PL355012A1 (pl)	2004-03-22	Szczepionka
NZ295877A (en)	1999-03-29	A vaccine comprising the helicobacter bacterium and its use
DE60033291D1 (de)	2007-03-22	Multi-komponenten impfstoff zum schutz vor krankheiten die durch haemophilus influenza und moxarella catarrhalis ausgelöst werden
AU6761301A (en)	2001-12-17	Adjuvant composition comprising fha protein or fragment of fha protein in free form
WO2000062803A3 (en)	2001-01-18	ppGpp AND pppGpp AS IMMUNOMODULATORY AGENTS
UA67249A (en)	2004-06-15	Strain paramixovirus-3 bovis "m-87" for the preparation of vaccine and diagnostic antigen
UA6097U (en)	2005-04-15	Process for preparation of multivac vaccine for prevention and treatment of widespread infectious diseases of animals caused by infectious associated etiologic agent
MY188912A (en)	2022-01-13	Attenuated bacteria for use in a vaccine
MY168662A (en)	2018-11-29	Attenuated bacteria for use in a vaccine